Expression and function of miR-155 in breast cancer

被引:14
|
作者
Liu, Jing [1 ]
Huang, WenHui [1 ]
Yang, HaiXia [2 ]
Luo, Ying [1 ]
机构
[1] Kunming Univ Sci & Technol, Lab Mol Genet Aging & Tumor, Fac Med, Kunming, Yunnan, Peoples R China
[2] Municipal Author Clin Jinan, Outpatient Dept, Jinan, Shandong, Peoples R China
关键词
miR-155; breast cancer; oncogenic miRNA; target genes; TRANSCRIPTION FACTOR FOXO3A; CLINICAL-SIGNIFICANCE; ABERRANT EXPRESSION; CELL-PROLIFERATION; GENE-EXPRESSION; MICRORNAS; GROWTH; METASTASIS; NETWORKS; PATHWAY;
D O I
10.1080/13102818.2015.1043946
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A major problem in the treatment of breast cancer at present is the lack of more sensitive and specific tumour biomarkers. MicroRNAs (miRNAs) were first discovered as important regulators of development in Caenorhabditis elegans, and their functions have been widely investigated. miR-155 is an oncogenic miRNA which has been explored mainly in leukaemia but is also known to play an important role in the progression of breast cancer. There is an accumulating body of evidence about additional roles of miR-155 in the development of breast cancer. In this mini-review, we provide an overview and update of miR-155 expression and its roles in breast cancer. We also attempt to summarize the current understanding of miR-155 regulation networks and speculate on the potential of miR-155 as a putative accessory parameter for diagnosis of breast cancer.
引用
收藏
页码:840 / 843
页数:4
相关论文
共 50 条
  • [31] THE EXPRESSION OF PLASMA MIR-155 AND MIR-146A IN RA PATIENTS
    Ye, Z.
    Yin, Z.
    Huang, J.
    Sun, H.
    Luo, X.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 342 - 343
  • [32] Inhibition of miR-155, a therapeutic target for breast cancer, prevented in cancer stem cell formation
    Zuo, Jiangcheng
    Yu, Yalan
    Zhu, Man
    Jing, Wei
    Yu, Mingxia
    Chai, Hongyan
    Liang, Chunzi
    Tu, Jiancheng
    CANCER BIOMARKERS, 2018, 21 (02) : 383 - 392
  • [33] Investigation the expression levels of miR-155 and miR-365 in the plasma of relapsed and unconscious breast cancer patients compared with healthy subjects
    Ghasemi-Dehkordi, Payam
    Hashemzadeh-Chaleshtori, Morteza
    GENETIC EPIDEMIOLOGY, 2018, 42 (07) : 700 - 701
  • [34] Simultaneous downregulation of miR-21 and miR-155 through oleuropein for breast cancer prevention and therapy
    Abtin, Maryam
    Alivand, Mohammad R.
    Khaniani, Mahmoud S.
    Bastami, Milad
    Zaeifizadeh, Mohammad
    Derakhshan, Sima M.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (09) : 7151 - 7165
  • [35] miR-155 and miR-122 Expression of Spermatozoa in Obese Subjects
    Lopez, Paulina
    Castro, Andrea
    Florez, Martha
    Miranda, Karen
    Aranda, Pilar
    Sanchez-Gonzalez, Cristina
    Llopis, Juan
    Arredondo, Miguel
    FRONTIERS IN GENETICS, 2018, 9
  • [36] Bioinformatic and metabolomic analysis reveals miR-155 regulates thiamine level in breast cancer
    Kim, Sinae
    Rhee, Je-keun
    Yoo, Hyun Ju
    Lee, Hee Jin
    Lee, Eun Ji
    Lee, Jong Won
    Yu, Jong Han
    Son, Byung Ho
    Gong, Gyungyup
    Kim, Sung Bae
    Singh, Shree Ram
    Ahn, Sei Hyun
    Chang, Suhwan
    CANCER LETTERS, 2015, 357 (02) : 488 - 497
  • [37] Interferon Regulatory Factor 3 Inhibits Astrocyte Inflammatory Gene Expression Through Suppression of the Proinflammatory miR-155 and miR-155
    Tarassishin, Leonid
    Loudig, Olivier
    Bauman, Avital
    Shafit-Zagardo, Bridget
    Suh, Hyeon-Sook
    Lee, Sunhee C.
    GLIA, 2011, 59 (12) : 1911 - 1922
  • [38] Analysis of microRNA expression profiling identifies miR-155 and miR-155* as potential diagnostic markers for active tuberculosis: a preliminary study
    Wu, Jing
    Lu, Chanyi
    Diao, Ni
    Zhang, Shu
    Wang, Sen
    Wang, Feifei
    Gao, Yan
    Chen, Jiazhen
    Shao, Lingyun
    Lu, Jingning
    Zhang, Xuelian
    Weng, Xinhua
    Wang, Honghai
    Zhang, Wenhong
    Huang, Yuxian
    HUMAN IMMUNOLOGY, 2012, 73 (01) : 31 - 37
  • [39] The expression of miR-155 and miR-181 in gastric cancer and their effects on clinical parameters and prognostic value
    Zhenfeng Shi
    Shuchun Lin
    Xiaorong Tang
    Hongli Zheng
    Fei Wang
    Wudong Tao
    Oncology and Translational Medicine, 2019, 5 (06) : 264 - 267
  • [40] Targeting miR-155 to resensitize lung cancer to chemotherapy
    Van Roosbroeck, K.
    Fanini, F.
    Setoyama, T.
    Ivan, C.
    Rodriguez-Aguayo, C.
    Zhang, X.
    Wistuba, I.
    Lopez-Berestein, G.
    Fabbri, M.
    Calin, G.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S116 - S116